Anavex Life Sciences (AVXL) Tops Q2 EPS by 2c

Anavex Life Sciences (NASDAQ: AVXL) reported Q2 EPS of ($0.13), $0.02 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Anavex Life Sciences (AVXL) click here.

You May Also Be Interested In

• Freedom Broker Downgrades Nucor (NUE) to Hold, 'Guides Conservative Earnings Yet Again'
• Electra Therapeutics indicated to open at $20, IPO priced at $15
• Pinduoduo (PDD) call put ratio 5.4 calls to 1 put into President Donald Trump and Chinese President Xi Jinping's summit